Home/Filings/4/0001193125-25-314511
4//SEC Filing

MULE EDWARD A 4

Accession 0001193125-25-314511

CIK 0001567892other

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 6:14 PM ET

Size

9.3 KB

Accession

0001193125-25-314511

Insider Transaction Report

Form 4
Period: 2025-12-08
Transactions
  • Purchase

    Common Stock

    2025-12-08$88.75/sh+130,974$11,623,9434,702,714 total
MULE EDWARD A
10% Owner
Transactions
  • Purchase

    Common Stock

    2025-12-08$88.75/sh+130,974$11,623,9434,702,714 total
Transactions
  • Purchase

    Common Stock

    2025-12-08$88.75/sh+130,974$11,623,9434,702,714 total
Footnotes (2)
  • [F1]Silver Point Capital, L.P. ("Silver Point") or its wholly owned subsidiaries are the investment managers of Silver Point Capital Fund, L.P., Silver Point Capital Offshore Master Fund, L.P., Silver Point Distressed Opportunity Institutional Partners, L.P., Silver Point Distressed Opportunity Institutional Partners Master Fund (Offshore), L.P., Silver Point Distressed Opportunities Fund, L.P., Silver Point Distressed Opportunities Offshore Master Fund, L.P., Silver Point Distressed Opportunity Institutional Partners II, L.P. and Silver Point Distressed Opportunity Institutional Partners II (Offshore), L.P. (the "Funds") and, by reason of such status, may be deemed to be the beneficial owner of all the reported securities held by the Funds.
  • [F2](Continued from footnote 1) Silver Point Capital Management, LLC ("Management") is the general partner of Silver Point and as a result may be deemed to be the beneficial owner of all securities held by the Funds. Messrs. Edward A. Mule and Robert J. O'Shea are each members of Management and as a result may be deemed to be the beneficial owner of all of the securities held by the Funds. Messrs. Mule and O'Shea disclaim beneficial ownership of the reported securities held by Funds except to the extent of their pecuniary interests.

Documents

1 file

Issuer

Keenova Therapeutics plc

CIK 0001567892

Entity typeother

Related Parties

1
  • filerCIK 0001029625

Filing Metadata

Form type
4
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 6:14 PM ET
Size
9.3 KB